Learn more

AXIOGENESIS AG

Overview
  • Total Patents
    51
  • GoodIP Patent Rank
    192,889
About

AXIOGENESIS AG has a total of 51 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GENUV INC, UNI FUR BODENKULTUR WIEN and NAT INST FOOD & DRUG CONTROL.

Patent filings per year

Chart showing AXIOGENESIS AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bohlen Heribert 46
#2 Kolossov Eugen 25
#3 Ehlich Andreas 20
#4 Schwengberg Silke 18
#5 Fleischmann Bernd 15
#6 Hescheler Juergen 12
#7 Kettenhofen Ralf 6
#8 Hescheler Jurgen 4
#9 Fink Leo 4
#10 Kopp Isabella 4

Latest patents

Publication Filing date Title
WO2012098260A1 A non-viral system for the generation of induced pluripotent stem (ips) cells
AU2009254153A1 Novel treatment of heart diseases
CA2565858A1 Assay for drug discovery based on in vitro differentiated cells
WO2005098425A1 Non-invasive, in vitro functional tissue assay systems
WO2005092378A2 Anti-vglut glutamate transporter antibodies for use in pain therapy
EP1644486A2 NOVEL METHOD FOR THE PREPARATION OF EMBRYOID BODIES (EBs) AND USES THEREOF
WO2005005662A2 Secreted proteins as markers for cell differentiation
EP3184629A1 Drug discovery based on in vitro generated tissue
WO2004000329A1 Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors
GB0313260D0 System for the cell-specific and development-specific selection of differentiating embryonic stem cells adult stem cells and embryonic germline cells
DE10136702A1 System for cell and development specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
EP1002080A1 Fluorescent proteins as cell-type specific reporter